SCHEMBL31111250

SCHEMBL31111250

Fc1cc(F)c2cn[nH]c2c1F

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 6/20 0.38
▸ EPAS1 Q99814 1/20 0.33
▸ CYP1A2 P05177 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30975396 0.82 NOS1 (0.36) METAP2EPAS1CYP1A2
SCHEMBL30536671 0.82 FGFR1 (0.36) METAP2CYP1A2
SCHEMBL22964672 0.82 NOS1 (0.36) METAP2EPAS1CYP1A2
SCHEMBL25369149 0.82 FGFR1 (0.36) METAP2CYP1A2
SCHEMBL31358029 0.79 METAP2 (0.36) METAP2CYP1A2
SCHEMBL24841969 0.77 METAP2 (0.36) METAP2
SCHEMBL31179208 0.76 KDM4E (0.39) METAP2EPAS1
SCHEMBL31248181 0.75 METAP2 (0.37) METAP2
SCHEMBL4731645 0.73 METAP2 (0.40) METAP2EPAS1CYP1A2
SCHEMBL31358108 0.73 METAP2 (0.40) METAP2EPAS1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673141-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME Sionna Therapeutics Inc. (US) 2026-01-07 — — EP disclosed
WO-2024182751-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME SIONNA THERAPEUTICS INC. (US) 2024-09-06 — — WO disclosed
Send feedback